Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Patch for Acute Musculoskeletal Pain
NCT03571737Phase 3Completed
- Sponsor
- East Carolina University
- Start
- Jun 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lidocaine 10% oropharyngeal spray in acute musculoskeletal pain (2 arms), sponsored by East Carolina University. Primary endpoint: Change in Numerical Pain Rating Scale at 60 months. Started Jun 2018; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
acute musculoskeletal pain
Beyond the preview
Go deeper on NCT03571737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03571737.